Merck On A Mission To Introduce Automation To Fertility Treatment
Healthcare giant Merck is on a mission to introduce automation to fertility treatment and improve patient outcomes. The German company, already a leader in fertility drugs, aims to expand its market position by delivering innovative device technologies.
You may also be interested in...
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.
Belgian start-up miDiagnostics has closed a €14m investment round to accelerate development of its silicon-chip-based diagnostics platform. The company believes the blood analyzer could deliver rapid test results in multiple settings.